Interaction between ESR1 and HLA-DR2 may contribute to the development of MS in women

Neurology

Volumn 56, Issue 9, 2001, Pages 1246-1247

  Mattila, Kari M ^a   Luomala, M ^a   Lehtimaki T ^a   Laippala, P ^b   Koivula, T ^a   Elovaara, I ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TAMPERE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; HLA DR2 ANTIGEN;

ADULT; AGED; ALLELISM; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REGRESSION ANALYSIS;

EID: 0035826890     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.56.9.1246     Document Type: Article

References (7)

1. Sex differences in autoimmune disease: Focus on multiple sclerosis
2. Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood
3. The combination of HLA-DR1 and HLA-DR53 protects against MS
4. Genetics of multiple sclerosis
5. The increased susceptibility of women to multiple sclerosis
6. Etiology and pathogenesis of multiple sclerosis
7. Estrogen receptors in human nontarget tissues: Biological and clinical implications